Buchmann, Nikolaus
Scholz, Markus
Lill, Christina M.
Burkhardt, Ralph
Eckardt, Rahel
Norman, Kristina
Loeffler, Markus
Bertram, Lars
Thiery, Joachim
Steinhagen-Thiessen, Elisabeth
Demuth, Ilja
Funding for this research was provided by:
German Federal Ministry of Education and Research (16SV5536K, 16SV5538, 16SV5837 and 16SV5537)
Article History
Received: 1 March 2017
Accepted: 2 August 2017
First Online: 2 September 2017
Compliance with ethical standards
:
: Dr. Steinhagen-Thiessen reports grants and personal fees from Sanofi, personal fees from MSD, Fresenius, personal fees from Amgen and Chiesi, outside the submitted work. Dr. Demuth reports grants from Sanofi, personal fees from uniQure biopharma B.V., outside the submitted work. Dr. Scholz received funding from Merck Serono in the framework of a pharmacokinetic modelling project not related to the present work. All other authors had nothing to disclose.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the 1975 Declaration of Helsinki, as revised in 2008 (5).
: Informed consent was obtained from all patients for being included in the study.